Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Treasury Shares (2016 - 2025)

Pediatrix Medical (MD) has disclosed Treasury Shares for 16 consecutive years, with $15000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Treasury Shares rose 650.0% to $15000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $15000.0, a 650.0% increase, with the full-year FY2024 number at $200000.0, up 227.87% from a year prior.
  • Treasury Shares was $15000.0 for Q2 2025 at Pediatrix Medical, down from $109000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $4.5 million in Q4 2022 to a low of -$83000.0 in Q3 2021.
  • A 5-year average of $559466.7 and a median of $50000.0 in 2022 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: plummeted 165.6% in 2021, then soared 40837.5% in 2022.
  • Pediatrix Medical's Treasury Shares stood at $172000.0 in 2021, then surged by 2541.86% to $4.5 million in 2022, then tumbled by 98.66% to $61000.0 in 2023, then surged by 227.87% to $200000.0 in 2024, then plummeted by 92.5% to $15000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Treasury Shares are $15000.0 (Q2 2025), $109000.0 (Q1 2025), and $200000.0 (Q4 2024).